These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 23978486)

  • 21. Increased neurosteroid sensitivity--an explanation to symptoms associated with chronic work related stress in women?
    Bäckström T; Bixo M; Nyberg S; Savic I
    Psychoneuroendocrinology; 2013 Jul; 38(7):1078-89. PubMed ID: 23177572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems.
    Birzniece V; Bäckström T; Johansson IM; Lindblad C; Lundgren P; Löfgren M; Olsson T; Ragagnin G; Taube M; Turkmen S; Wahlström G; Wang MD; Wihlbäck AC; Zhu D
    Brain Res Rev; 2006 Aug; 51(2):212-39. PubMed ID: 16368148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.
    Schmidt PJ; Purdy RH; Moore PH; Paul SM; Rubinow DR
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1256-60. PubMed ID: 7962316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA receptors, progesterone and premenstrual dysphoric disorder.
    Sundström Poromaa I; Smith S; Gulinello M
    Arch Womens Ment Health; 2003 Feb; 6(1):23-41. PubMed ID: 12715262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder.
    Bäckström T; Ekberg K; Hirschberg AL; Bixo M; Epperson CN; Briggs P; Panay N; O'Brien S
    Psychoneuroendocrinology; 2021 Nov; 133():105426. PubMed ID: 34597899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle.
    Hantsoo L; Epperson CN
    Neurobiol Stress; 2020 May; 12():100213. PubMed ID: 32435664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women.
    Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder.
    Segebladh B; Bannbers E; Moby L; Nyberg S; Bixo M; Bäckström T; Sundström Poromaa I
    Arch Womens Ment Health; 2013 Apr; 16(2):131-7. PubMed ID: 23329007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance to allopregnanolone with focus on the GABA-A receptor.
    Turkmen S; Backstrom T; Wahlstrom G; Andreen L; Johansson IM
    Br J Pharmacol; 2011 Jan; 162(2):311-27. PubMed ID: 20883478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse mood effects during postmenopausal hormone treatment in relation to personality traits.
    Björn I; Bäckström T; Lalos A; Sundström-Poromaa I
    Climacteric; 2006 Aug; 9(4):290-7. PubMed ID: 16857659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progesterone selectively increases amygdala reactivity in women.
    van Wingen GA; van Broekhoven F; Verkes RJ; Petersson KM; Bäckström T; Buitelaar JK; Fernández G
    Mol Psychiatry; 2008 Mar; 13(3):325-33. PubMed ID: 17579609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats.
    Gulinello M; Smith SS
    J Pharmacol Exp Ther; 2003 May; 305(2):541-8. PubMed ID: 12606703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids.
    Stiernman L; Dubol M; Comasco E; Sundström-Poromaa I; Boraxbekk CJ; Johansson M; Bixo M
    Transl Psychiatry; 2023 Apr; 13(1):124. PubMed ID: 37055419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women with polycystic ovary syndrome have elevated serum concentrations of and altered GABA(A) receptor sensitivity to allopregnanolone.
    Hedström H; Bäckström T; Bixo M; Nyberg S; Wang M; Gideonsson I; Turkmen S
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):643-50. PubMed ID: 25929428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
    Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
    Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder.
    Gingnell M; Morell A; Bannbers E; Wikström J; Sundström Poromaa I
    Horm Behav; 2012 Sep; 62(4):400-6. PubMed ID: 22814368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors.
    Schumacher M; Mattern C; Ghoumari A; Oudinet JP; Liere P; Labombarda F; Sitruk-Ware R; De Nicola AF; Guennoun R
    Prog Neurobiol; 2014 Feb; 113():6-39. PubMed ID: 24172649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels.
    Bernardi F; Pluchino N; Pieri M; Begliuomini S; Lenzi E; Puccetti S; Casarosa E; Luisi M; Genazzani AR
    Neuroendocrinology; 2006; 83(5-6):348-59. PubMed ID: 16931878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of allopregnanolone in depression and anxiety.
    Schüle C; Nothdurfter C; Rupprecht R
    Prog Neurobiol; 2014 Feb; 113():79-87. PubMed ID: 24215796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder.
    Hantsoo L; Grillon C; Sammel M; Johnson R; Marks J; Epperson CN
    Psychopharmacology (Berl); 2021 Oct; 238(10):2985-2997. PubMed ID: 34292344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.